This Web Site is committed to the memory of Janis Morrow.

Human liver   

Cirrhosis

Main Page


Index: Keep Updated Cirrhosis Research


Biochemical Indicators of Cirrhosis

  • Alanine aminotransferase (ALT) levels are usually higher than aspartate aminotransferase (AST) levels, but that finding may be reversed in patients who have cirrhosis.

  • Alkaline phosphatase and gamma glutamyl transpeptidase are usually normal. If elevated, they may indicate cirrhosis.

  • Low platelet and white blood cell counts and raised levels of serum globulins (including immunoglobulins and rheumatoid factor) are frequent in patients with severe fibrosis or cirrhosis, providing clues to the presence of advanced disease.

  • The enzymes lactate dehydrogenase and creatine kinase are usually normal.

  • Albumin levels, bilirubin, and prothrombin time are normal until late-stage disease.

  • Iron and ferritin levels may be slightly elevated


Low-dose Pegylated Interferon Maintenance Therapy Does Not Reduce Clinical Outcomes despite Persistent HCV Suppression

Advanced liver disease and surgery risk

Therapy in Decompensated HCV-infected Cirrhotic Patients

2010


HALT-C Formula for Predicting Cirrhosis

Liver disease: Early signs you may be missing

Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial

Watch a video:  Diet and Cirrhosis

HealthWise: Cirrhosis


ALL ABOUT CIRRHOSIS


Page One


Symptoms of Cirrhosis

“How will I know if I get cirrhosis?

Risk Factors in People with Chronic Hepatitis

Natural History of Cirrhosis

Natural History Of Compensated Cirrhosis

Natural history of decompensated hepatitis C virus-related cirrhosis.

A study of 200 patients


Page Two


Spleen Removal Can Help Hepatitis C Patients with Cirrhosis Tolerate Treatment

Spleen?
Do we need it?

Issues in Cirrhosis


Page Three


What is cirrhosis of the liver?

Important Information for Patients with Chronic Liver Disease and/or Cirrhosis

Complications of Cirrhosis: Clinical Perspectives and Implications 


Page Four


Physical Finding  Suggestive of Cirrhosis (with photos)

Page Five


Complications of Cirrhosis
 

Page Six


More on Compensated Liver disease
Cirrhosis--A Liver Problem
Treatment of Chronic Hepatitis C in Decompensated Cirrhotics

Page Seven


 

Hepatitis C and Liver Transplantation.

Management of Hepatitis C in the Pre-Transplant Patient

Natural history and predictors of disease progression
Prophylaxis and Treatment of Recurrent Hepatitis C
Grading system for cirrhosis: the Child-Pugh score  
Staging Cirrhosis
Long-term management of cirrhosis
What Lifestyle Factors Can Help Manage Cirrhosis ?

 


Medical Problems and Cirrhosis

Page Eight


Esophageal Varices

Encephalopathy (Hepatic or Portal-systemic)

 

Ocera Therapeutics Presents Data On AST-120 In Patients With Hepatic Encephalopathy At The European Association For The Study Of Liver Disease


 

Video

2009 Annual Meeting of the European Association for the Study of the Liver*

April 22-26, 2009 | Copenhagen, Denmark

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Peter Ferenci, MD, summarizes basic understanding of hepatic encephalopathy and data on new management options

 

http://www.clinicaloptions.com


Cirrhosis-Blood Pressure Link Studied
Management of Bleeding in the Cirrhotic Patient
Reducing Salt for Edema, Advanced Cirrhosis or Ascites
 

Small esophageal varices in cirrhotic patients

Cirrhosis and Bleeding: The Need for Very Early Management

 

Do Ammonia Levels Correlate with Hepatic Encephalopathy?

Antibiotic prophylaxis after variceal hemorrhage reduces incidence of early
rebleeding.

Normal protein diet for episodic hepatic encephalopathy

Hepatic Encephalopathy

Screening for Varices in Patients With Cirrhosis:
Where Do We Stand?


Page Nine


Maintenance Therapies for Hepatitis C

Future Trends of HCV-related Cirrhosis and Hepatocellular Carcinoma in Greece after Adjusting for Access to Peginterferon and Ribavirin

A Sustained Viral Response Predicts a Significant Decrease in Clinical Complications Among Patients with Advanced Fibrosis or Cirrhosis

Pegasys Plus Ribavirin Is Safe and Effective Treatment for Patients with Chronic Hepatitis C and Compensated Cirrhosis

Medications and Help for Patients with Cirrhosis         

Page Ten


Medication Effective In Prevention of Variceal Bleeding

Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis

 

Future Therapies

Given the frequency, morbidity, and mortality associated with recurrent bleeding, novel drugs and interventions have been studied.

 

New Approach for Minimal Hepatic Encephalopathy?

The Benefit of Natural Therapies


Warnings for Patients who have Cirrhosis  

 

Page Eleven


Milk Thistle: Effects on Liver Disease and Cirrhosis and Clinical Adverse Effects

Diet And Nutrition - Could Caffeine Lower The Risk For Developing Liver Cirrhosis?

Heavy Alcohol Use Greatly Increases Cirrhosis Risk in Hepatitis C-Infected Patients
Manufacturers Appeal Germany's Kava Kava Ban
Women Pay Heavy Price for Alcohol Abuse
Warnings :Celebrex And Vioxx
Threat From the Ocean
Testimony on Acetaminophen Use and Liver Injury

 


Articles


HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial -

M1032 - The occurrence of malignancy in patients with liver cirrhosis-more than HCC

Metabolics/Belly Fat Advance HCV Disease

The Effect of Liver Fibrosis and Cirrhosis on SVR in 4913 Patients with Hepatitis C: Results from the Win-R Trial -

Retreatment with Peginterferon Alfa-2a (Pegasys) Plus Ribavirin of Nonresponders with Cirrhosis/Advanced Fibrosis to Peginterferon Alfa-2b (PegIntron)

Coffee and tea intake may lower chronic liver disease risk

Most chronic hepatitis C sufferers will develop cirrhosis in later life

Peginterferon Alfa-2b Plus Ribavirin Elicits Sustained Response in Decompensated HCV Patients

Milk Thistle: Effects on Liver Disease and Cirrhosis and Clinical Adverse Effects

Care of the Cirrhotic Patient

Treatment of HCV in Cirrhotic Patients 

Dispelling myths in the treatment of hepatic encephalopathy

Response to Hepatitis C Therapy Can Last for Years

Articles of Interest:

ABC of diseases of liver, pancreas, and biliary system: Portal hypertension-1: varices

Cirrhosis and Chronic Liver Failure Diagnosis and Evaluation

Cirrhosis and Chronic Liver Failure Complications and Treatment

 

 


copyright © 2003-2008 Janis and Friends Hepatitis C Web Site|  design )by carter

Design downloaded from Zeroweb.org: Free website templates, layouts, and tools.